Any feedback?
Literature summary for 3.1.4.35 extracted from
- Peyronie’s disease: evolving surgical management and the role of phosphodiesterase 5 inhibitors (2009), ScientificWorldJournal, 9, 822-845.
Application
| Application | Comment | Organism |
|---|---|---|
| medicine | PDE5 inhibitors show a potential antifibrotic affect against Peyronie's disease plaque in animal models | Homo sapiens |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| sildenafil | - |
Homo sapiens |  |
| tadalafil | - |
Homo sapiens | |
| vardenafil | - |
Homo sapiens | |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| PDE5 | - |
Homo sapiens |
| phosphodiesterase 5 | - |
Homo sapiens |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
